A Nomogram to Predict Breast Tumor Regression Patterns after Neoadjuvant Chemotherapy Based on Baseline Characteristics

Xiaosheng Zhuang,Minyi Cheng,Liulu Zhang,Fei Ji,Teng Zhu,Ciqiu Yang,Mei Yang,Hongfei Gao,Jieqing Li,Kun Wang

DOI: https://doi.org/10.21203/rs.3.rs-57234/v1

2020-01-01

Abstract:Background Breast cancers show different regression patterns after neoadjuvant chemotherapy. Certain regression patterns are associated with more reliable margins in breast-conserving surgery. Our study aims to establish a nomogram based on clinicopathological factors and laboratory indicators to predict regression patterns in breast cancer patients.Methods We retrospectively reviewed 320 patients with stage II-III breast cancer who received neoadjuvant chemotherapy and had definitive surgery in our center from January 2016 to December 2019. Tumor regression patterns were categorized as type 1 (concentric regression + pCR) and type 2 (multifocal residues + SD + PD) based on mass pathological results. A multivariate logistic regression model was applied to distinguish predictive factors for tumor regression patterns. A nomogram was built based on five predictive factors from the multivariate logistic regression model.Results Molecular subtypes were not significantly associated with tumor regression patterns. Multivariate analysis identified five independent indicators: menopausal status, estrogen receptor status, T stage, N stage and lymphocyte to monocyte ratio. The nomogram yielded an area under the curve (AUC) of 0.70 (95% confidence interval 0.62-0.78) based on these factors. The calibration plot accompanied by the Hosmer–Lemeshow goodness-of-fit (GOF) test (p-value =0.9) showed good consistency between the estimated probabilities and the actual rate of type 1 cases.Conclusion HR+/HER2- breast cancers are more likely to have type 2 regression after neoadjuvant chemotherapy. Five baseline factors, including clinicopathological factors and laboratory indexes, were incorporated to establish a nomogram, which exhibited a satisfactory discriminatory ability for predicting different patterns of tumor regression.